R. D. Nikolova et al. / Tetrahedron 60 (2004) 10335–10342
10341
Method E. A solution of the coumarin (0.27 g, 1 mmol) and
the corresponding phosphite (5 mmol) in glacial acetic acid
(2 mL) was irradiated with ultrasound at low temperature
(ice-water-bath) until the starting coumarin was consumed
(TLC-monitoring). The reaction mixture was decomposed
on ice-water (50 mL). The obtained crystals were filtrated
and washed with water to neutral pH.
1170, 1055, 1030 cmK1. 1H NMR (300 MHz): dZ7.98 (m;
20, 60-H, 2H), 7.64 (dddd as tt, J0Z7.4, 1.3 Hz; 40-H, 1H),
7.50 (dddd as tt, JZ7.4, 1.5 Hz; 3 , 50-H, 2H), 7.32 (dddd as
tt, JZ7.7, 2.0 Hz; 7-H, 1H), 7.21 (ddd as dt, JZ8.0, 2.0 Hz;
5-H, 1H), 7.08–7.14 (m, 6-, 8-H, 2H), 5.20 (dd, JZ14.0,
0.9 Hz; 3-H, 1H), 4.11–4.23 (m; POCH2), 3.88 (dq, JZ8.2,
7.1 Hz; POCH2), 3.73 (bd, 2JHCPZ23.3 Hz; 4-H, 1H), 1.36
(t, JZ7.1 Hz; CH3, 3H), 1.24 (t, JZ7.0 Hz; CH3, 3H). 13
C
NMR (75.4 MHz): dZ192.0 (d, 3JCPZ17.1 Hz; CO), 163.3
4.3.1. Dimethyl 3-(1-hydroxyaethylidene)-2-oxochro-
man-4-ylphosphonate (8a). From 2a or 7 and trimethyl
phosphite. Method C: 0.28 g, 95%, white crystals, mpZ
127–129 8C (ethyl acetate), (lit.21,22 129–130 8C).
3
3
(d, JCPZ2.2 Hz; C-2), 151.3 (d, JCPZ5.7 Hz; C-8a),
3
134.4 (C-40), 133.2 (C-10), 130.0 (d, JCPZ4.4 Hz; C-5),
129.7 (d, 5JCPZ4.2 Hz; C-7), 129.2 (C-20,-60), 129.1 (C-30,
4
4
-50), 124.8 (d, JC2PZ3.2 Hz; C-6), 117.2 (d, JCPZ3.2 Hz;
2
C-8), 114.7 (d, JCPZ7.7 Hz; C-4a), 63.8 (d, JCOP
Z
4.3.2. Diethyl 3-(1-hydroxyaethylidene)-2-oxochroman-
4-ylphosphonate (8b). From 2a or 7 and triethyl phosphite.
Method C: 0.31 g, 95%, white crystals, mpZ145–148 8C
(ethyl acetate), (lit.21,22 147–148 8C).
7.5 Hz; POCH2), 63.4 (d, 2JCOPZ7.2 Hz; POCH2), 49.2 (d,
2JCPZ3.5 Hz; C-3), 38.9 (d, 1JCPZ143.5 Hz; C-4), 16.3 (d,
3JCPZ6.2 Hz; CH3), 16.2 (d, JCPZ5.5 Hz; CH3). MS m/z
3
(5): 389 (MHC) (57), 388 (MC) (21), 282 (74), 250 (58),
228 (92), 173 (41), 146 (52), 118 (43) 105 (100), 78 (92), 77
(79).
4.3.3. Dimethyl 3-benzoyl-2-oxochroman-4-ylphospho-
nate (12/13a). From 3-benzoylcoumarin 10 and trimethyl
phosphite. Method D: 0.34 g, 94%, white crystals, mpZ
120–134 8C (methanol), (mixture of the two tautomers
12a$13a, with a 9:1 ratio (1H NMR), which on staying the
sample in the NMR tube for about 1 week (CDCl3) changed
to w1:1); [Found: C, 60.07; H, 4.90. C18H17O6P requires C,
60.00; H, 4.76%]; IR (CH3Cl): nZ1780, 1700, 1625, 1060,
4.3.5. Ethyl 4-(dimethoxyphosphoryl)-2-oxo-3-chroma-
necarboxylate (14a). From ethyl 2-oxo-2H-1-benzopyran-
3-carboxylate 11 and trimethyl phosphite. Method C:
0.19 g, 58%, colorless needles, mpZ94–95 8C (methanol);
[Found: C, 50.84; H, 5.00. C14H17O7P requires C, 51.23; H,
5.22%]; IR (CH3Cl): nZ1795, 1755, 1620, 1160, 1030,
1030 cmK1 1H NMR (300 MHz), enol-form (12a): dZ
.
1045 cmK1 1H NMR (300 MHz): dZ7.30–7.37 (m; 5-,
.
13.290 (s; OH,01H), 7.58–7.65 (m; 20-, 60-H, 2H), 7.46–7.54
(m; 3 -, 50-, 4 -H, 3H), 7.26–7.37 (m; 5-H, 7-H, 2H), 7.12–
7-H, 2H), 7.17 (ddd as dt, JZ7.5, 1.0 Hz; 6-H, 1H), 7.10 (d,
3
3
2
JZ8.5 Hz; 8-H, 1H), 4.15 (dd, JHHZ1.3 Hz, JHP
Z
7.19 (m; 6-H, 8-H, 2H), 4.45 (d, JHPZ23.9 Hz; 4-H, 1H),
11.1 Hz; 3-H, 1H), 4.12 (dq, 3JZ7.1 Hz, JHPZ2.6 Hz;
6
3
3
3.49 (d, JHPZ10.6 Hz; OCH3, 3H), 3.41 (d, JHP
Z
2
10.6 Hz; OCH3, 3H). Keto-form (13a): 7.96–7.99 (m, 20-,
60-H, 2H),07.65 (dddd as tt, JZ7.4, 1.4 Hz; 40-H, 1H), 7.48–
7.55 (m; 3 -H, 50-H, 2H), 7.34 (dddd as tt, JZ7.7, w2.0 Hz;
7-H, 1H), 7.22 (ddd as dt, JZ8.2, w2.1 Hz; 5-H, 1H), 7.11–
7.17 (m; 6-, 8-H, 2H), 5.19 (dd, JHPZ13.7 Hz, JHH
0.8 Hz; 3-H, 1H), 3.80 (bd, JHPZ23.4 Hz; 4-H, 1H), 3.81
OCH2, 2H), 3.95 (bd, JHPZ22.6 Hz; 4-H, 1H), 3.75 (d,
3JHPZ10.8 Hz; POCH3, 3H), 3.75 (d, JHPZ10.8 Hz;
3
POCH3, 3H), 1.11 (t, JZ7.1 Hz; CH3, 3H). 13C NMR
(75.4 MHz): dZ166.0 (d, 3JCPZ22.7 Hz; C]O), 162.2 (d,
3JCPZ2.2 Hz; C-2), 151.2 (d, JCPZ5.3 Hz; C-8a), 130.1
3
3
3
Z
(d, 3JCPZ5.2 Hz; C-5), 129.9 (d, 5JCPZ3.4 Hz; C-7), 125.1
(d, 4JCPZ3.2 Hz; C-6), 117.3 (d, 4JCPZ3.2 Hz; C-8), 115.4
2
3
3
(d, JHPZ10.8 Hz; OCH3, 3H), 3.68 (d, JHPZ10.8 Hz;
2
2
OCH3, 3H). 13C NMR (75.4 MHz), enol-form (12a): dZ
(d, JCCPZ7.5 Hz; C-4a), 63.0 (OCH2), 53.9 (d, JCCOP
Z
7.4 Hz; POCH3), 53.7 (d, 2JCOPZ7.4 Hz; POCH3), 46.9 (d,
3
3
175.5 (d, JCPZ6.7 Hz; ]COH), 169.1 (d, JCPw1 Hz;
2JCPZ2.3 Hz; C-3), 38.7 (d, JCPZ144.5 Hz; C-4), 13.8
1
3
4
C-2), 150.9 (d, JCPZ5.5 Hz; C-8a), 133.6 (d, JCP
Z
(CH3). MS m/z (%): 328 (MC) (22), 282 (7), 255 (100), 219
(24), 173 (87), 146 (11), 118 (13), 79 (6).
3
2.2 Hz; C-10), 130.9 (C-40), 129.9 (d, JCPZ4.5 Hz; C-5),
5
129.3 (d, JCP!5 Hz; C-7), 128.8 (C-30,-50), 128.2 (C-20,
4
2
-60), 125.0 (d, JCPZ3.3 Hz; C-6), 117.7 (d, JCPZ7.5 Hz;
C-4a), 117.1 (d, 4JCPZ3.9 Hz; C-8), 89.7 (d, 2JCPZ9.9 Hz;
4.3.6. Ethyl 4-(diethoxyphosphoryl)-2-oxo-3-chromane-
carboxylate (14b). From ethyl 2-oxo-2H-1-benzopyran-3-
carboxylate 11 and triethyl phosphite. Method C: 0.32 g,
88%, light-yellow oil; [Found: C, 53.59; H, 5.96.
C16H21O7P requires C, 53.93; H, 5.94%]; IR (CH3Cl): nZ
2
2
C-3), 53.6 (d, JCOPZ7.6 Hz; POCH3), 53.3 (d, JCOP
Z
7.4 Hz; POCH3), 37.6 (d, 1JCPZ140.8 Hz; C-4). Keto-form
3
3
(13a): 191.7 (d, JCPZ17.5 Hz; CO), 163.2 (d, JCP-
3
w0.5 Hz; C-2), 151.2 (d, JCPZ6.5 Hz; C-8a), 134.5
3
1790, 1750, 1625, 1600, 1170, 1060sh, 1030 cmK1 1H
.
(C-40), 133.2 (C-10), 129.4 (d, JCPZ2.9 Hz, C-5), 129.2
5
(C-20,-60), 129.2 (d, JCP!5.2 Hz; C-7), 129.2 (C-30,-50),
NMR (250 MHz) dZ7.29–7.36 (m; 5-, 7-H, 2H), 7.16 (dd
as t, JZ7.2 Hz; 6-H, 1H), 7.09 (d, JZ8.2 Hz; 8-H, 1H), 4.15
(d, JZ14.4 Hz; 3-H, 1H), 3.92–4.61 (m; CH2O, 6H), 3.90
(d, 2JHPZ24.2 Hz; 4-H, 1H), 1.32 (t, JZ7.0 Hz; CH3, 3H),
1.21 (t, JZ7.0 Hz; CH3, 3H), 1.11 (t, JZ7.1 Hz; CH3, 3H).
125.0 (d, 4JCPZ3.3 Hz; C-6), 117.3 (d, 4JCPZ3.6 Hz; C-8),
2
2
114.5 (d, JCPZ7.8 Hz; C4a), 54.1 (d, JCOPZ6.7 Hz;
POCH3), 53.8 (d, 2JCOPZ7.6 Hz; POCH3), 49.1 (d, 2JCCP
Z
1
3.4 Hz; C-3), 38.5 (d, JCPZ143.9 Hz; C-4). MS m/z (%):
361 (MHC) (51), 360 (MC) (20), 328 (18), 254 (48), 174
(81), 146 (52), 118 (49), 111 (79), 105 (50), 76 (100).
3
13C NMR (62.59 MHz) dZ166.1 (d, JCPZ21.5 Hz; CO),
3
3
162.3 (d, JCPZ2.0 Hz; C-2), 151.2 (d, JCPZ4.7 Hz;
3
5
C-8a), 130.0 (d; JCPZ4.8 Hz; C-5), 129.7 (d, JCP
Z
Z
4.3.4. Diethyl 3-benzoyl-2-oxochroman-4-ylphosphonate
(13b). From 3-benzoylcoumarin 10 and triethyl phosphite.
Method D: 0.27 g, 69%, white solid, mpZ106–108 8C
(ethanol); [Found: C, 61.77; H, 5.65. C20H21O6P requires C,
61.86; H, 5.45%]; IR (CH3Cl): nZ1780, 1700, 1620, 1500,
3.7 Hz; C-7), 124.9 (d, 4JCPZ3.2 Hz; C-6), 117.1 (d, 4JCP
2
3.2 Hz; C-8), 115.6 (d, JCPZ7.2 Hz; C-4a), 63.5 (d,
2JCOPZ7.1 Hz; POCH2), 63.2 (d, JCOPZ7.1 Hz;
2
2
POCH2), 62.8 (COOCH2), 46.9 (d, JCPZ2.7 Hz; C-3),
39.5 (d, JCPZ144.2 Hz; C-4), 16.2 (d, JCPZ5.7 Hz;
1
3